Virtual sessions lessen seniors’ cancer pain, study finds
By
Aaron Dorman
Apr 10, 2024
A 10-minute VR session was able to provide lasting pain relief for cancer patients, offering an alternative to opioids, a new study showed.
Mental health apps can provide short-term benefit for seniors with depression, study shows
By
Aaron Dorman
Mar 29, 2024
Mental health apps for seniors can help alleviate stress in the short-term, but cannot replace caregivers, a recent study shows.
AAN: Dementia more common with essential tremor than in the general population
Mar 08, 2024
Dementia rates, however, were lower than a comparison cohort of people with Parkinson’s disease.
Digital drawing test shows promise in detecting early-stage dementia
By
Aaron Dorman
Feb 28, 2024
A drawing test that involves sketching a clock was able to better identify early dementia than paper-and-pencil alternatives, research shows.
Higher pancreatic fat percentage linked to lower cognition in men
Feb 27, 2024
Higher pancreatic fat was linked to lower cognition and brain volumes in middle-aged men at high risk for Alzheimer’s disease.
New app puts popular cognitive assessment tool onto smartphones
By
Aaron Dorman
Feb 23, 2024
A new app allows users to take a rapid version of the Montreal Cognitive Assessment on their smartphone, for early warning signs of dementia.
ASA: Nearly one in five people develop dementia after stroke
Feb 08, 2024
In the first year after stroke, there is an almost threefold higher risk for dementia.
Visionary Alzheimer’s forecasting software gets FDA approval
By
Aaron Dorman
Jan 30, 2024
A newly regulated Alzheimer’s software tool offers clarity on whether the condition is likely to progress to dementia in someone with mild cognitive impairment.
Monoclonal antibodies provide small benefits in Alzheimer’s disease
Jan 26, 2024
Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.
Lower cutoff points for Montreal cognitive assessment needed
Jan 17, 2024
A high false-positive rate was seen when used in primary care with a diverse patient population.